deepull receives FDA Breakthrough Device Designation for its UllCORE Bloodstream Infection Test

Retrieved on: 2024-12-02 15:33:39

Tags for this article:

Bacterial diseases

Blood culture

Antimicrobial resistance

Infection

Bloodstream infection

Medical laboratory

Clinical metagenomic sequencing

Pathogenic Escherichia coli

u.s. food and drug administration

Barcelona

Click the tags to see associated articles and topics

deepull receives FDA Breakthrough Device Designation for its UllCORE Bloodstream Infection Test. View article details on hiswai:

Excerpt

AOP Wins Nod for Critical Care Atrial Fibrillation Drug. November 27, 2024. ·. 208 min read. ·. Heather McKenzie · Pictured: Alnylam's headquarters ...

Article found on: www.biospace.com

View Original Article